The AJMC® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.
Michael Snyder Discusses How Precision Health Measurements Can Impact Diabetes Detection and Management
Michael Snyder, PhD, professor and chair of genetics at the Stanford University School of Medicine, discusses the ways in which precision health measurements can aid physicians in detecting and better managing diabetes.
Improved Periconception A1C Linked to Reduction in Adverse Pregnancy Outcomes
A reduction in glycated hemoglobin (A1C) may result in improved perinatal and maternal outcomes among women with prepregnancy diabetes, according to results of a cohort study published in JAMA Network Open.
Machine Learning Predicts Incidence of Gestational Diabetes
Using advanced machine learning models, researchers in China were able to accurately predict incidence of gestational diabetes among pregnant women during their first trimester.
Top 5 Most-Read Diabetes Articles of 2020
Advancements in coverage for diabetes technology and improvement in diabetic retinopathy screening rates appear on this year’s list of most-read diabetes articles.
Review Details Relationship Between Frailty, Diabetes in Older Populations
The identification and assessment of frailty, defined as a state of increased vulnerability to adverse health outcomes resulting from loss of physiological reserve, should become a routine aspect of diabetes care, authors of a systematic review and meta-analysis published in The Lancet Health Longevity argued.
Empagliflozin Linked to 20% Drop in Care Costs for T2D, CVD
An outcomes-based agreement conducted by Boehringer Ingelheim and Highmark found that use of Jardiance (empagliflozin) among adults with type 2 diabetes (T2D) and known cardiovascular disease (CVD) was associated with a total cost of care savings of over 20%.
Poxel's PXL770 Shows Promise in Patients With NASH, T2D
Results from a phase 2 trial show PXL770 yielded consistently greater responses in high-risk patients with comorbid nonalcoholic steatohepatitis (NASH) and type 2 diabetes (T2D) compared with placebo.
Experts Discuss Benefits, Limitations of Pediatric Obesity Interventions
During a session at the at the 18th annual World Congress Insulin Resistance, Diabetes & Cardiovascular Disease presented by the Metabolic Institute of America, experts outlined the benefits and limitations of pharmacological, surgical, and lifestyle interventions for pediatric patients with obesity.
Dr Paul Zimmet Outlines COVID-19, Diabetes Challenges and Lessons Learned From the Pandemic
In a session at the 18th annual World Congress Insulin Resistance, Diabetes & Cardiovascular Disease presented by the Metabolic Institute of America, experts discussed challenges faced by patients with diabetes in the wake of the coronavirus disease 2019 (COVID-19) pandemic and lessons learned from the crisis.
Kentucky Telemedicine Program Increases Diabetic Retinopathy Screening Rates
Large telemedicine diabetic retinopathy screening networks based in federally designated safety-net clinics may be able to increase screening access and compliance among otherwise underscreened populations.
NDPS Data Show Minor Weight Loss Can Almost Halve T2D Risk
For individuals currently in high-risk glycemic categories, losing 2 to 3 kg (4.5-6.5 lb) in combination with increased physical activity over 2 years nearly halved the risk of developing type 2 diabetes (T2D).
Most Patients With T2D Classified as "High Risk" for Fatal Heart Attack, Stroke
Half of patients with type 2 diabetes (T2D) exhibit very high cardiovascular risk while the majority are at a high risk of fatal heart attack or stroke, according to new research published in the European Journal of Preventive Cardiology.
Reducing Racial, Ethnic Disparities in Diabetes Prevalence Requires a Multifaceted Approach
Lowering the higher rates of diabetes seen among racial and ethnic minorities requires solutions to address all of the major factors that contribute to diabetes prevalence.
Race Impacts DME Treatment Efficacy, Study Finds
Black individuals with diabetic macular edema (DME) exhibited a significantly lower likelihood of visual acuity improvement following intravitreal bevacizumab treatment compared with White and Hispanic patients.
Two-Year Data Show Combined Efficacy of GLP-1 RAs, SGLT2s for T2D
New data show combining glucagon-like peptide-1 receptor agonist (GLP-1 RA) exenatide plus sodium–glucose cotransporter-2 (SGLT2) inhibitor dapagliflozin remains effective after 2 years for type 2 diabetes (T2D) uncontrolled with metformin.
What We’re Reading: J&J Loses Appeal; Opioid Settlement in the Works; Diabetes Prevention Results Released
A decision was upheld that Johnson & Johnson (J&J) must pay a $2.1-billion fine from a 2018 court decision; 3 major drug distributors face up to $18 billion in opioid-related fines; a new diabetes prevention platform may assist in symptom prevention.
Differences in Spending for Diabetes and Multiple Chronic Conditions in Michigan Medicare Beneficiaries
Diabetes and multiple chronic conditions increase overall Medicare spending, but spending increases even more in minority beneficiaries compared with White beneficiaries with similar comorbidity combinations.
CMS Proposes New Rules for CGM Coverage Among Medicare Beneficiaries
This week, CMS proposed changes to the Medicare Durable Medical Equipment Prosthetics, Orthic Devices and Supplies (DMEPOS) coverage and payment policies which would expand Medicare coverage for continuous glucose monitors (CGMs).
Contributor: Modern Medicine Meets House Calls—Caring for the Patient With Diabetes in 2020
Physicians agree that telehealth leads to better and more consistent patient care for patients and their families and provides many more touchpoints for patients with diabetes—all of which should continue after the pandemic in order to provide these patients with the best care going forward.
Weight Reduction Surgery Associated With Reduced Risk of Second Heart Attack in Obese Patients
In severely obese patients with previous myocardial infarction, metabolic surgery was associated with a lower risk of heart attack and new onset heart failure, according to study results published in Circulation.
Greater Green Tea, Coffee Consumption Associated With Lower Mortality Risk in T2D Population
Consuming more green tea and coffee was associated with reduced all-cause mortality among individuals with type 2 diabetes (T2D), according to the results of a prospective study published in BMJ Open Diabetes Research and Care.
Survey Highlights Challenges of Diabetes Management, Potential Impact of Technology
Results from a national survey conducted by the Association of Diabetes Care & Education Specialists show that individuals living with diabetes feel they are doing everything they can to manage the condition, yet believe more can be done.
Diabetes Risk Factors Dominate Top Causes of Global Mortality, Heighten COVID-19 Risks
New data estimates from the Global Burden of Disease Study published by The Lancet illustrate how rising rates of chronic disease and public health failures compounded over decades to worsen the coronavirus disease 2019 (COVID-19) pandemic.
Can an HIV Drug Help Prevent Diabetes?
Patients who received anti-inflammasome nucleoside reverse-transcriptase inhibitors (NRTIs)—drugs approved to treat HIV-1 and hepatitis B infections—exhibited a 33% reduced risk of developing type 2 diabetes (T2D), according to a meta-analysis published in Nature Communications.
What We’re Reading: Nobel Prize in Chemistry Awarded; Improving Diabetes Management; COVID-19 Vaccine Trial Still on Hold
Two women are awarded the Nobel Prize in Chemistry for CRISPR; Eli Lilly partners with DexCom, Inc; the US arm of AstraZeneca’s coronavirus disease 2019 (COVID-19) vaccine trial remains halted.
Study Highlights Persistent Racial Disparities in Insulin Pump Use Among Children With T1D
Racial disparities in insulin pump use among children with type 1 diabetes (T1D) have persisted over the past 15 years, independent of socioeconomic status.
NIH Funds First Network to Study Rare Forms of Diabetes
The National Insistutes of Health (NIH) study aims to discover new forms of diabetes, understand what makes them unique, and identify root causes.
Diabetes Drug May Hold Potential as COVID-19 Treatment
In patients with type 2 diabetes admitted to the hospital for coronavirus disease 2019 (COVID-19), treatment with sitagliptin at the time of hospitalization was associated with reduced mortality and improved clinical outcomes compared with standard-of-care treatment.
Progress Made in Diabetes Technology Coverage, Access Among Medicare Beneficiaries
Recently, 2 district courts secured a pair of victories for Medicare beneficiaries who use continuous glucose monitor technologies to manage their diabetes, while senators introduced bipartisan legislation aimed at increasing access to the Medicare Diabetes Prevention Program.
Ertugliflozin CV Outcomes in T2D Population Are Similar to Placebo
In patients with type 2 diabetes (T2D) and atherosclerotic cardiovascular disease, results from a multicenter, double-blind trial show that treatment with ertugliflozin is noninferior to placebo with respect to major adverse cardiovascular events.
2 Clarke Drive Cranbury, NJ 08512